Market Overview:
The global infection control apparel market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the infection control apparel market can be attributed to the increasing incidence of hospital-acquired infections (HAIs) and rising demand for advanced protection against various microorganisms. In addition, the increasing number of surgical procedures is also propelling the growth of this market. Based on type, the global infection control apparel market is segmented into isolation gowns, chemotherapy gowns, lab coats and jackets. The isolation gowns segment is projected to account for the largest share of this market in 2018. This can be attributed to their growing use in hospitals across the globe as a means of preventing HAIs. Based on application, this market is segmented into hospitals, ambulatory and surgical centers, and clinics.
Product Definition:
Infection control apparel refers to clothing that is worn in order to protect the wearer from coming into contact with infectious agents. This type of clothing typically includes gowns, masks, gloves, and eyewear. The purpose of infection control apparel is to prevent the spread of infection from one person to another. It is important for healthcare workers and other individuals who may come into contact with infectious agents to wear appropriate protection in order to minimize the risk of exposure.
Isolation Gowns:
Isolation gowns are used by healthcare professionals to protect themselves and their patients from pathogens. They are also used in medical settings where there is a risk of exposure to blood or other potentially infectious fluids. The demand for isolation gowns is expected to grow at a lucrative rate over the forecast period owing to increasing awareness about infection control, growing prevalence of Hospital-Acquired Infections (HAIs), and rising incidence of pandemic diseases such as Ebola & Swine Flu.
Chemotherapy Gowns:
Chemotherapy gowns are protective clothing used by healthcare professionals to prevent contamination from patient's skin or fluids during chemotherapy, radiation therapy, and other treatment procedures. They are also used in infection control apparel to provide protection against blood and other body fluids that may be infectious.
The global cancer gowns & infection control apparel market size was valued at USD 1.6 billion in 2016.
Application Insights:
Based on application, the global infection control apparel market is segmented into hospitals, ambulatory and surgical centers, clinics, and others. Hospitals held the largest share in 2017 owing to increasing government initiatives for improving healthcare infrastructure at a global level. For instance, in 2015 Germany announced plans for building 200 new hospitals within five years as part of its initiative to improve healthcare facilities across rural areas. This will help reduce transmission of infections between patients in these facilities.
The use of infection prevention garments during surgeries helps prevent skin-to-skin contact with infected wounds or other body fluids that may transmit infections such as HIV or hepatitis through blood or other body fluids that may contain infectious microorganisms like bacteria and viruses. The Centers for Disease Control and Prevention (CDC) has recommended their usage during procedures where there is potential exposure to blood or other potentially infectious materials by direct contact (such as surgery), indirect contact (such as handling), or via surface contamination (injection).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the increasing number of healthcare-associated infections, rising preference for disposable products, and government initiatives promoting infection control standards. For instance, in April 2018, gowns made by 3M were awarded a Design Excellence Award by Healthcare Infection Control (HIC) Association of America for its innovative design that makes patient care safer.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure and growing awareness about hygiene & safety among patients and visitors at hospitals as well as clinics. In addition, an increase in chronic diseases leading to high demand for medical services is anticipated will drive this regional market further.
Growth Factors:
- Increasing awareness about the importance of infection control and hygiene among healthcare professionals and general population.
- Rising incidence of hospital-acquired infections (HAIs) due to increasing number of surgeries, growing number of patients with multiple chronic diseases, and increasing use of invasive devices.
- Stringent government regulations for infection control in hospitals and other healthcare settings.
- Growing demand for disposable infection control apparel products from hospitals, clinics, long-term care facilities, laboratories, food processing plants, etc., due to their superior performance characteristics over traditional fabrics/materials used in making such products.
- Technological advancements in fabric technologies that are resulting in development of advanced infection control apparel products with better performance characteristics
Scope Of The Report
Report Attributes
Report Details
Report Title
Infection Control Apparel Market Research Report
By Type
Isolation Gowns, Chemotherapy Gowns, Lab Coats and Jackets
By Application
Hospitals, Ambulatory and Surgical Centers, Clinics
By Companies
Cardinal Health, DuPont Medical Fabrics, Owens & Minor, Medline Industries, 3M, Lindström, Ansell, Delta Plus, Protective Industrial Products, Lakeland Industries
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Infection Control Apparel Market Report Segments:
The global Infection Control Apparel market is segmented on the basis of:
Types
Isolation Gowns, Chemotherapy Gowns, Lab Coats and Jackets
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory and Surgical Centers, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Cardinal Health
- DuPont Medical Fabrics
- Owens & Minor
- Medline Industries
- 3M
- Lindström
- Ansell
- Delta Plus
- Protective Industrial Products
- Lakeland Industries
Highlights of The Infection Control Apparel Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Isolation Gowns
- Chemotherapy Gowns
- Lab Coats and Jackets
- By Application:
- Hospitals
- Ambulatory and Surgical Centers
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infection Control Apparel Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infection control apparel is clothing and accessories that help protect healthcare workers from infection. This includes items like masks, gowns, gloves, and other protective gear.
Some of the key players operating in the infection control apparel market are Cardinal Health, DuPont Medical Fabrics, Owens & Minor, Medline Industries, 3M, LindstrƒÂ¶m, Ansell, Delta Plus, Protective Industrial Products, Lakeland Industries.
The infection control apparel market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Infection Control Apparel Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Infection Control Apparel Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Infection Control Apparel Market - Supply Chain
4.5. Global Infection Control Apparel Market Forecast
4.5.1. Infection Control Apparel Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Infection Control Apparel Market Size (000 Units) and Y-o-Y Growth
4.5.3. Infection Control Apparel Market Absolute $ Opportunity
5. Global Infection Control Apparel Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Infection Control Apparel Market Size and Volume Forecast by Type
5.3.1. Isolation Gowns
5.3.2. Chemotherapy Gowns
5.3.3. Lab Coats and Jackets
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Infection Control Apparel Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Infection Control Apparel Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Ambulatory and Surgical Centers
6.3.3. Clinics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Infection Control Apparel Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Infection Control Apparel Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Infection Control Apparel Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Infection Control Apparel Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Infection Control Apparel Demand Share Forecast, 2019-2026
9. North America Infection Control Apparel Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Infection Control Apparel Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Infection Control Apparel Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Ambulatory and Surgical Centers
9.4.3. Clinics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Infection Control Apparel Market Size and Volume Forecast by Type
9.7.1. Isolation Gowns
9.7.2. Chemotherapy Gowns
9.7.3. Lab Coats and Jackets
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Infection Control Apparel Demand Share Forecast, 2019-2026
10. Latin America Infection Control Apparel Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Infection Control Apparel Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Infection Control Apparel Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Ambulatory and Surgical Centers
10.4.3. Clinics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Infection Control Apparel Market Size and Volume Forecast by Type
10.7.1. Isolation Gowns
10.7.2. Chemotherapy Gowns
10.7.3. Lab Coats and Jackets
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Infection Control Apparel Demand Share Forecast, 2019-2026
11. Europe Infection Control Apparel Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Infection Control Apparel Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Infection Control Apparel Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Ambulatory and Surgical Centers
11.4.3. Clinics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Infection Control Apparel Market Size and Volume Forecast by Type
11.7.1. Isolation Gowns
11.7.2. Chemotherapy Gowns
11.7.3. Lab Coats and Jackets
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Infection Control Apparel Demand Share, 2019-2026
12. Asia Pacific Infection Control Apparel Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Infection Control Apparel Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Infection Control Apparel Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Ambulatory and Surgical Centers
12.4.3. Clinics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Infection Control Apparel Market Size and Volume Forecast by Type
12.7.1. Isolation Gowns
12.7.2. Chemotherapy Gowns
12.7.3. Lab Coats and Jackets
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Infection Control Apparel Demand Share, 2019-2026
13. Middle East & Africa Infection Control Apparel Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Infection Control Apparel Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Infection Control Apparel Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Ambulatory and Surgical Centers
13.4.3. Clinics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Infection Control Apparel Market Size and Volume Forecast by Type
13.7.1. Isolation Gowns
13.7.2. Chemotherapy Gowns
13.7.3. Lab Coats and Jackets
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Infection Control Apparel Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Infection Control Apparel Market: Market Share Analysis
14.2. Infection Control Apparel Distributors and Customers
14.3. Infection Control Apparel Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Cardinal Health
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DuPont Medical Fabrics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Owens & Minor
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Medline Industries
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. 3M
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Lindström
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Ansell
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Delta Plus
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Protective Industrial Products
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Lakeland Industries
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
